The examination about pharmacokinetics of Tazobactam/Piperacillin [2.25g*2times/day] in the patients who have the blood purification therapy
Phase 4
- Conditions
- The patients who have blood purification therapy in the intensive care unit and who need to take Tazobactam / Piperacillin [2.25g*2times/day]
- Registration Number
- JPRN-UMIN000019162
- Lead Sponsor
- Hyogo college of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who don't have continuous hemodiafilltration therapy The patients who don't take Tazobactam / Piperacillin
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We measure drug level in blood of patients and calculate parameters of population. We compare them with clinical datas and examine relevances blood concentration and expression of side effects.
- Secondary Outcome Measures
Name Time Method